World-Renowned Physician and HIV Researcher Joins Samaritan's Advisory Board
03 oct. 2007 10h39 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 3, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life saving drugs announced today the appointment of James E.K. Hildreth, M.D., a world...
Samaritan CEO to Speak On Pharma Partnering Panel At 7th Annual Biotech in Europe Investor Forum
01 oct. 2007 10h29 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs announced today its CEO, Dr. Janet Greeson, has been invited to speak on a...
Samaritan to Host 2007 Annual Meeting October 23, 2007
28 sept. 2007 10h09 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Sept. 28, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it will host its annual shareholders meeting on Tuesday,...
Update: Samaritan Agrees to Amend Due Date to Receive Second Upfront Payment of $8.6 Million From Pharmaplaz for Its HIV Out-Licensing Deal
24 sept. 2007 14h25 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Sept. 24, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs announced today they have amended the due date to October 16, 2007 for...
EUSA Pharma Signs Exclusive Distribution Agreement With Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and Cyprus
20 sept. 2007 10h09 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Sept. 20, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that it has signed an exclusive distribution agreement...
FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II Study
18 sept. 2007 09h21 HE
|
Samaritan Pharmaceuticals, Inc.
Three Investigational New Drugs (IND) in Pipeline
- Phase II HIV Drug SP-01A
- Phase I Alzheimer's Drug SP-233 Caprospinol
- Phase II Cushing's syndrome SP-6300
LAS VEGAS, Sept. 18, 2007...
Samaritan to Talk Up Its Alzheimer's, HIV and Stem Cell Drugs On NBC Affiliate KVBC Channel 3
24 août 2007 11h15 HE
|
Samaritan Pharmaceuticals, Inc.
- Don't Miss the CEO of Samaritan On "News 3 At Sunrise"
Sunday, August 26th
- Samaritan is One of Nevada's Largest Pharmaceutical Companies
- Samaritan Videos to Highlight the Substantial...
Samaritan Licenses Tumor Inhibiting Cancer Drugs That Also Distinguish Cancerous Tumors to Improve On Chemotherapy
21 août 2007 09h43 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 21, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, announced today that it has entered into an exclusive licensing agreement with...
Samaritan Licenses Method to Identify Novel Anti-Tumor Drugs to Increase Cancer Compounds in Pipeline
16 août 2007 11h04 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 16, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce it has exclusively licensed a patent application...
Samaritan's Novel Blood Test to Diagnose Alzheimer's is Granted Patent by European Patent Office
14 août 2007 11h10 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 14, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that a patent application entitled "NEUROSTEROIDS AS...